The Role of CA‐125 in the Management of Ovarian Cancer

Oncologist - United States
doi 10.1634/theoncologist.2-1-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Diagnostic Performance of CA 125, HE4, and Risk of Ovarian Malignancy Algorithm for Ovarian Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

The Epidemiology of CA-125 in Women Without Evidence of Ovarian Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

Gynecologic Oncology
GynecologyOncologyObstetrics
2008English

Nadir CA-125 Level as Prognosis Indicator of High-Grade Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

The Role of Surgery in the Management of Epithelial Ovarian Cancer

Cancer Control
MedicineOncologyHematology
2011English

Risk of Diagnosis of Ovarian Cancer After Raised Serum CA 125 Concentration: A Prospective Cohort Study

BMJ
1996English

The Relation Between Ca 125, Cect Abdomen & Pelvis and Histopathological Features in Ovarian Neoplasms

Journal of Evolution of Medical and Dental Sciences
2019English

CA 125 Half-Life Breakpoint Between a “Good” and “Poor” Prognosis in Patients With Ovarian Cancer

International Journal of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2005English

The Role of Prophylactic Oophorectomy in the Management of Hereditary Breast & Ovarian Cancer Syndrome

2012English

Serum McA, CA 125 and CA 19.9 Determination in Primary Breast Cancer

Biochemical Society Transactions
Biochemistry
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy